跳转至内容
Merck
CN
  • Protocol to generate cardiac pericytes from human induced pluripotent stem cells.

Protocol to generate cardiac pericytes from human induced pluripotent stem cells.

STAR protocols (2023-04-29)
Mengcheng Shen, Shane Rui Zhao, Yaser Khokhar, Li Li, Yang Zhou, Chun Liu, Joseph C Wu
摘要

Cardiac pericytes are a critical yet enigmatic cell type within the coronary microvasculature. Since primary human cardiac pericytes are not readily accessible, we present a protocol to generate them from human induced pluripotent stem cells (hiPSCs). Our protocol involves several steps, including the generation of intermediate cell types such as mid-primitive streak, lateral plate mesoderm, splanchnic mesoderm, septum transversum, and epicardium, before deriving cardiac pericytes. With hiPSC-derived cardiac pericytes, researchers can decipher the mechanisms underlying coronary microvascular dysfunction. For complete details on the use and execution of this protocol, please refer to Shen et al.1.

材料
货号
品牌
产品描述

Sigma-Aldrich
抗肌动蛋白,α-平滑肌抗体,小鼠单克隆, clone 1A4, purified from hybridoma cell culture
Sigma-Aldrich
硫酸软骨素蛋白聚糖抗体,克隆9.2.27, clone 9.2.27, Chemicon®, from mouse
Sigma-Aldrich
抗- 钙蛋白单克隆抗体 小鼠抗, clone hCP, ascites fluid